Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cancer Genetics Inc 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 USA

P: 201-528-9200 F: 201-528-9201

Description:

Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 14,707
Shares Outstanding, K 27,750
Annual Sales, $ 29,120 K
Annual Net Income, $ -20,880 K
Last Quarter Sales, $ 7,040 K
Last Quarter Net Income, $ -3,630 K
36-Month Beta 1.10
% of Insider Shareholders 21.30%
% of Institutional Shareholders 15.86%

Growth:

1-Year Total Return -79.62%
3-Year Total Return -83.39%
5-Year Total Return -96.16%
5-Year Revenue Growth 577.21%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/22/18
Earnings Per Share ttm -0.80
EPS Growth vs. Prev Qtr 18.75%
EPS Growth vs. Prev Year 18.75%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

CGIX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.60
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -81.99
Return-on-Assets (Before Tax) -40.24
Net Margin % N/A
Debt/Equity 0.03
Price/Sales 0.51
Price/Cash Flow N/A
Price/Book 0.86
Book Value/Share -0.62
Interest Coverage -9.78
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar